5-(3-[3-(guanidino)propylcarbamoyl]benzylaminocarboyl)-1,3-dihydropyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione hydrochloride | 1225189-98-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-(3-[3-(guanidino)propylcarbamoyl]benzylaminocarboyl)-1,3-dihydropyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione hydrochloride
• 英文别名: N-[[3-[3-(diaminomethylideneamino)propylcarbamoyl]phenyl]methyl]-1,3-dioxo-6H-pyrrolo[3,4-c]carbazole-5-carboxamide;hydrochloride
• CAS: 1225189-98-9
• 化学式: C₂₇H₂₅N₇O₄*ClH
• 分子量: 548.001
• InChiKey: SRXAENUERJAKSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.95
• 重原子数：
  39
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  185
• 氢给体数：
  7
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  5-(3-[3-(di-tert-butoxycarbonylguanidino)propylcarbamoyl]benzylaminocarboyl)-1,3-dihydropyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione 在 盐酸 作用下， 以 四氢呋喃 、 乙酸乙酯 为溶剂， 反应 4.5h， 以70%的产率得到5-(3-[3-(guanidino)propylcarbamoyl]benzylaminocarboyl)-1,3-dihydropyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione hydrochloride
  参考文献：
  名称：

  Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors

  摘要：

  The structure-activity relationship (SAR) of 5-substituted pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione derivatives 5 was investigated for their potential as Chk1 inhibitors for possible chemo- and radio-potentiators in anticancer chemotherapies. In silico virtual screening helped to optimize the substituent on the phenyl ring, and led to identification of the m-carbamoyl group among the 117 analogues tested. Further optimization studies focusing on the docking model of 15 in the active site of Chk1 revealed that 32b (IC50 = 2.8 nM) was a more potent inhibitor than UNC-01. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.09.042

文献信息

• Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors
  作者：Yuki Sako、Satoshi Ichikawa、Akiko Osada、Akira Matsuda

  DOI：10.1016/j.bmc.2010.09.042

  日期：2010.11.15

  The structure-activity relationship (SAR) of 5-substituted pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione derivatives 5 was investigated for their potential as Chk1 inhibitors for possible chemo- and radio-potentiators in anticancer chemotherapies. In silico virtual screening helped to optimize the substituent on the phenyl ring, and led to identification of the m-carbamoyl group among the 117 analogues tested. Further optimization studies focusing on the docking model of 15 in the active site of Chk1 revealed that 32b (IC50 = 2.8 nM) was a more potent inhibitor than UNC-01. (C) 2010 Elsevier Ltd. All rights reserved.